regulatory
confidence high
sentiment positive
materiality 0.90
Personalis gets CMS revised reimbursement rates for NeXT Personal breast cancer test
Personalis, Inc.
- CMS revised reimbursement for Personalis' NeXT Personal Dx Breast MRD test to $4,266 effective Dec 1, 2025
- Reimbursement for NeXT Personal Single Plasma Test set at $1,164, available up to six years post-treatment
- Medicare coverage for the NeXT Personal Dx test is available once per cancer diagnosis for stage II/III breast cancer